SE7904284L - Farmaceutiska beredningar som innehaller prostaglandiner samt forfarande for framstellning av dem - Google Patents

Farmaceutiska beredningar som innehaller prostaglandiner samt forfarande for framstellning av dem

Info

Publication number
SE7904284L
SE7904284L SE7904284A SE7904284A SE7904284L SE 7904284 L SE7904284 L SE 7904284L SE 7904284 A SE7904284 A SE 7904284A SE 7904284 A SE7904284 A SE 7904284A SE 7904284 L SE7904284 L SE 7904284L
Authority
SE
Sweden
Prior art keywords
preparation
procedures
pharmaceutical preparations
preparations containing
containing prostaglandins
Prior art date
Application number
SE7904284A
Other languages
Unknown language ( )
English (en)
Other versions
SE450930B (sv
Inventor
I S Watts
P H Marsden
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SE7904284L publication Critical patent/SE7904284L/sv
Publication of SE450930B publication Critical patent/SE450930B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7904284A 1978-05-17 1979-05-16 Farmaceutisk beredning innehallande prostacyklin eller vissa derivat derav SE450930B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2017578 1978-05-17

Publications (2)

Publication Number Publication Date
SE7904284L true SE7904284L (sv) 1979-11-18
SE450930B SE450930B (sv) 1987-08-17

Family

ID=10141640

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7904284A SE450930B (sv) 1978-05-17 1979-05-16 Farmaceutisk beredning innehallande prostacyklin eller vissa derivat derav

Country Status (28)

Country Link
US (1) US4335139A (sv)
EP (1) EP0005768B1 (sv)
JP (1) JPS54163809A (sv)
KR (1) KR830000527B1 (sv)
AT (2) AT365926B (sv)
AU (1) AU525695B2 (sv)
BE (1) BE876296A (sv)
CA (1) CA1141661A (sv)
CH (1) CH641044A5 (sv)
CS (1) CS214798B2 (sv)
DE (2) DE2920020A1 (sv)
DK (1) DK156004C (sv)
ES (1) ES480597A1 (sv)
FI (1) FI68359C (sv)
FR (1) FR2425856A1 (sv)
GR (1) GR68452B (sv)
HU (1) HU182746B (sv)
IL (1) IL57298A (sv)
IT (1) IT1116840B (sv)
LU (1) LU81272A1 (sv)
MC (1) MC1265A1 (sv)
NL (1) NL7903871A (sv)
NZ (1) NZ190462A (sv)
PH (1) PH15850A (sv)
PL (1) PL134004B1 (sv)
SE (1) SE450930B (sv)
SU (1) SU978715A3 (sv)
ZA (1) ZA787353B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010002A1 (de) * 1980-03-15 1981-10-01 Hoechst Ag, 6000 Frankfurt Prostaglandine enthaltende pharmazeutische zubereitung
GB8814438D0 (en) * 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
JPH0240325A (ja) * 1988-06-17 1990-02-09 Wellcome Found Ltd:The 医薬用化合物
JP3421330B2 (ja) * 2000-11-02 2003-06-30 持田製薬株式会社 ビダラビン注射用乾燥製剤
EP1238670A1 (en) * 2001-03-07 2002-09-11 Bruce Daniels Composition and method for treating and preventing cardiovascular disease and hypertension.
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
DE602006005423D1 (de) * 2005-06-29 2009-04-16 Verisfield Uk Ltd Pharmazeutische Zusammensetzungen von Risperidon in wässriger Lösung
WO2007092343A2 (en) 2006-02-03 2007-08-16 Scidose Llc Novel epoprostenol formulation and method of making thereof
EP2711024B1 (en) 2007-09-07 2019-03-06 United Therapeutics Corporation Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
HU231031B1 (hu) 2016-03-23 2019-12-30 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Megnövelt stabilitású epoprostenol nátrium és eljárás előállítására
DE202024100435U1 (de) 2023-02-14 2024-02-22 Tomasz Dąbrowski Zaunfeld zum Aufbau einer Reitbande

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036954A (en) 1973-11-02 1977-07-19 Yamanouchi Pharmaceutical Co., Ltd. Stable prostaglandin E group-containing formulation
GB1504437A (en) 1974-03-08 1978-03-22 Dunlop Ltd Rubberplastics composites
DE2515001C2 (de) * 1975-04-04 1986-10-02 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandin enthaltende gefriergetrocknete Pulver
US3997587A (en) 1975-06-26 1976-12-14 Syntex (U.S.A.) Inc. D1- and 8R-9-fluoro-prostadienoic acid derivatives
US4005133A (en) 1975-10-14 1977-01-25 The Upjohn Company PGF2.sub.α, L-Arginine salt
FR2351112A1 (fr) * 1975-10-21 1977-12-09 Wellcome Found Derive de prostaglandine et medicament contenant ce derive
US4062964A (en) 1975-12-03 1977-12-13 Ciba-Geigy Corporation Antifertility-combinations
GB1583961A (en) * 1976-05-11 1981-02-04 Wellcome Found Prostacyclin and derivatives thereof
JPS542335A (en) * 1977-05-20 1979-01-09 Wellcome Found Medical composition

Also Published As

Publication number Publication date
PL134004B1 (en) 1985-07-31
DE2920020A1 (de) 1979-11-29
FI791565A7 (fi) 1979-11-18
AT365926B (de) 1982-02-25
JPS6358810B2 (sv) 1988-11-17
FR2425856B1 (sv) 1982-06-25
DK156004B (da) 1989-06-12
NL7903871A (nl) 1979-11-20
IL57298A (en) 1983-09-30
KR830000527B1 (ko) 1983-03-12
ATA363479A (de) 1981-07-15
AU4704279A (en) 1979-11-22
DE2966046D1 (en) 1983-09-15
LU81272A1 (fr) 1979-12-07
HU182746B (en) 1984-03-28
DE2920020C2 (sv) 1988-09-01
FR2425856A1 (fr) 1979-12-14
CA1141661A (en) 1983-02-22
BE876296A (fr) 1979-11-16
CS214798B2 (en) 1982-05-28
DK156004C (da) 1989-11-06
EP0005768A1 (en) 1979-12-12
SU978715A3 (ru) 1982-11-30
GR68452B (sv) 1981-12-30
US4335139A (en) 1982-06-15
DK201879A (da) 1979-11-18
ZA787353B (en) 1980-08-27
FI68359C (fi) 1985-09-10
PL215627A1 (sv) 1981-08-07
MC1265A1 (fr) 1980-03-28
ES480597A1 (es) 1980-08-16
IT7949064A0 (it) 1979-05-16
CH641044A5 (de) 1984-02-15
ATE4411T1 (de) 1983-08-15
AU525695B2 (en) 1982-11-25
EP0005768B1 (en) 1983-08-10
IT1116840B (it) 1986-02-10
PH15850A (en) 1983-04-13
IL57298A0 (en) 1979-09-30
SE450930B (sv) 1987-08-17
FI68359B (fi) 1985-05-31
JPS54163809A (en) 1979-12-26
NZ190462A (en) 1982-05-31

Similar Documents

Publication Publication Date Title
NO854194L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende antracyklinglykosider.
NO865079L (no) Fremgangsmaate for fremstilling av stabiliserte humanvevplasminogenaktivatorpreparater.
NO179359C (no) Fremgangsmåte for fremstilling av farmasöytisk preparat inneholdende somatostatinanaloger.
NO791205L (no) 2-(2-tenoyltio)-propionylglycin, fremgangsmaate for fremstilling derav og farmasoeytiske formuleringer som inneholder forbindelsen
NO921382D0 (no) Amidinofenylalaninderivater, samt fremstilling, anvendelse og preparater inneholdende forbindelsene
AU525695B2 (en) Pharmaceutical formulations of prostacyclin
NO883261D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
AR227386A1 (es) Procedimiento para la preparacion de lh-rh o de analogos de lh-rh,con empleo de(glu-his(dnp)-oh
MX3897E (es) Un procedimiento para la preparacion de composiciones insecticidas que contienen (6,7,8,9,10,10-hexacloro-1,5,5a,6,9,9a,-hexahidro-6,9-metano-2,4,3,-benzodioxatiepin-3-oxido)
IT8620208A0 (it) Eteri del 7-ossabicicloeptano sostituiti quali analoghi di prostaglandine e relative composizioni farmaceutiche.
SE8400453D0 (sv) Lekemedelspreparat for antitumorverkan
IT7831403A0 (it) Procedimento per la preparazione di miscele perossidiche.
GB2021581A (en) Stabilisation of PGl2 derivatives
SE8503447D0 (sv) Farmaceutiska och kosmetiska kompositioner, innehallande dihydroxi-1,8-fenyl-10-antron-9 som verksam bestandsdel, samt sett att framstella den verksamma foreningen
IT7921685A0 (it) Procedimento per la preparazione di un agente scintillografico.
ZA811672B (en) Pharmaceutical formulations containing prostaglandin
DK420479A (da) N-iso-propyl-s-(1,6-dihydro-6-(thio)oxopyridazin (1)-yl-methyl)-thiolphosphorsyreesteramider fremgangsmaade til fremstilling heraf samt forbondelsernes anvendelse som skadedyrebekaempelsesmidler
NO812893L (no) Aminohydroksylfenylforbindelser, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder forbindelsene, samt forbindelsens anvendelse
SE8503513L (sv) Farmaceutiska och kosmetiska kompositioner, vilka som verksam bestandsdel innehaller acetyl-10-triacetoxi-1,8,9-antracen
NL187974C (nl) O-gesubstitueerde oximderivaten, werkwijze voor de bereiding daarvan, alsmede farmaceutische preparaten, die dergelijke verbindingen bevatten.
IT7921319A0 (it) Procedimento per la preparazione di clorozocitina e relative formulazioni farmaceutiche.
DK163058C (da) Triazolethanolderivat, farmaceutiske praeparater indeholdende forbindelsen, forbindelsen til anvendelse som laegemiddel samt fremgangsmaade til fremstilling af forbindelsen

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7904284-2

Effective date: 19900518

Format of ref document f/p: F